Navigation Links
Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
Date:5/31/2010

that could affect these forward-looking statements include, but are not limited to, developments affecting Dendreon's business and prospects, including commercialization of PROVENGE. Information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. Dendreon cautions investors not to place undue reliance on the forward-looking statements contained in this press release. All forward-looking statements are based on information currently available to Dendreon on the date hereof, and Dendreon undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
2. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
3. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
4. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
5. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
6. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
7. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
9. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
10. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
11. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research ... announced the addition of the "Marine Biotechnology ... their offering. Annual estimates and forecasts ... Also, a seven-year historic analysis is provided for ... from primary and secondary research. This ...
(Date:3/30/2015)... VALENCIA, Calif. , March 30, 2015 /PRNewswire/ ... Schloffman has decided to leave Cochlear to join ... mentor and friend, Jeff Greiner , who ... the Chief of Market Development and will be ... use of Valencia,s coin-sized ...
(Date:3/30/2015)... March 30, 2015  Edison Nation Medical, the ... search for product innovations to assist seniors in ... uncovered during the 8-week search will be presented ... Invention ideas can be submitted through a secure, ... May 28, 2015. The objective of ...
Breaking Medicine Technology:Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... 18 In a study,published by the Journal of ... when cancer patients used a handheld computer,before office visits ... were significantly more likely to address these,potentially debilitating symptoms ... Corporation (NYSE: TOC ; TSX: TOC). The ...
... Johnson Pharmaceutical,Research & Development, L.L.C., today announced ... clinically cure 81% of patients with,nosocomial pneumonia ... (VAP) in studies comparing doripenem to commonly ... presented in both oral and poster sessions ...
Cached Medicine Technology:Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study 2Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study 3Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study 4New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias 2New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias 3New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias 4New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias 5
(Date:3/30/2015)... (PRWEB) March 30, 2015 Southern Med ... and defective medical devices, has filed a Mirena ... whose baby died following his premature birth in 2012. ... Circuit Court, alleges that the Mirena IUD failed to ... also made the device difficult to remove. The inability ...
(Date:3/30/2015)... “We are pleased to announce three volunteer pilot recipients ... Los Angeles,” said Mark Wolper, Chair of Endeavor Awards. ... nationwide call for nominations. , The awards recipients ... with LightHawk and Stephen Purello of Angel Flight Southeast. ... receive a $15,000 contribution from the Endeavor Awards Ceremony ...
(Date:3/30/2015)... March 30, 2015 Innovaacom, a leading ... worldwide, today announced it is expanding its services into ... this area of the world comes at a time ... consumer demand for better healthcare. A rapidly growing aging ... improvements and advances in medicine in Asia. “We are ...
(Date:3/30/2015)... Vancouver personal injury lawyer firm, Jiwa Law Corporation, ... up by the firm are settled before they go ... the interests of their clients without them having to ... across as an achievement for the personal injury lawyers, ... their client, without compromising their rights. , By ...
(Date:3/30/2015)... This report studies the global ... forecast period of 2014 to 2019. This market ... 6.5% from 2014 to 2019. , Further Inquiry ... the global pharmacovigilance and drug safety software market ... basis of functionality, namely, adverse event reporting software, ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:2015 Endeavor Awards Recipients Announced 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... doubt that undergoing infertility treatment is stressful, with high ... Mind/body therapies designed to help women reduce stress earlier ... but little is known specifically about the impact of ... A new study published June 1 in ...
... AUGUSTA, Ga. - Nitric oxide gas appears to directly ... of sickle cell disease, Georgia Health Sciences University researchers ... that stick together, forming long chains that ultimately deform ... small blood vessels and pain, said Dr. C. Alvin ...
... (DDW) is the largest international gathering of physicians, ... hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by ... Diseases, the American Gastroenterological Association (AGA) Institute, the ... for Surgery of the Alimentary Tract, DDW takes ...
... , MONDAY, May 9 (HealthDay News) -- A new study finds ... have been diagnosed with and then survive a cancer, shining a ... It,s not the first time that researchers have noted differences ... are at higher risk of becoming infected with HIV, while lesbians ...
... HealthDay Reporter , MONDAY, May 9 (HealthDay News) -- ... than younger people experience, new research shows. "Age did ... major adverse events, but it did predict a longer period ... slated to present the findings Monday at Digestive Diseases Week ...
... cells appears to affect how effectively the immune system,s killer ... at the Ragon Institute of MGH, MIT and Harvard have ... cells, a process that should lead to labeling infected cell ... great variability in the stability of resulting protein segments, variations ...
Cached Medicine News:Health News:Mind/body program increases pregnancy rates in IVF treatment 2Health News:Nitric oxide impacts source of sickle cell pain crisis 2Health News:UNC research highlights at 2011 Digestive Disease Week 2Health News:Gay Men More Likely to Have Had Cancer 2Health News:Weight-Loss Surgery Seems No Riskier for Seniors 2Health News:Step in breakdown of HIV proteins essential to recognition, destruction of infected cells 2
... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...
... in Endoscopic cases, it is extremely popular to ... Surgical Light. This combination affords the surgeon ... adopt an uncomfortable pose. The Single Light ... Monitoring System. As such the light can ...
... Triple Light Head is commonly found in Heart rooms ... with the third light head being used to illuminate ... triple is also a favorite in trauma rooms should ... at the same time. With 137,000 Lux output ...
... of your procedural specialty, whether it ... NUVO Monitoring System will complement the ... ergonomics and advanced high-resolution display technology. ... mobile carts, the NUVO Monitor provides ...
Medicine Products: